A new study conducted at the University of Texas MD Anderson Cancer Center investigates the use of neurofeedback, aimed at helping cancer survivors control symptoms of chemotherapy-induced nerve damage. According to lead investigator Sarah Prinsloo, "neurofeedback has no known side effects, can be used in combinations with other treatments and is reasonable cost-effective."
To read more about this study, click here.
No comments:
Post a Comment